New York-Structural GenomiX Research Consortium (NYSGXRC): A large scale center for the protein structure initiative

Jeffrey B. Bonanno, Steven C. Almo, Anne R. Bresnick, Mark R. Chance, Andras Fiser, S. Swaminathan, J. Jiang, F. William Studier, Lawrence Shapiro, Christopher D. Lima, Theresa M. Gaasterland, Andrej Sali, Kevin Bain, Ingeborg Feil, Xia Gao, Don Lorimer, Aurora Ramos, J. Michael Sauder, Steven R. Wasserman, Spencer EmtageKevin L. D'Amico, Stephen K. Burley

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

Structural GenomiX, Inc. (SGX), four New York area institutions, and two University of California schools have formed the New York Structural GenomiX Research Consortium (NYSGXRC), an industrial/academic Research Consortium that exploits individual core competencies to support all aspects of the NIH-NIGMS funded Protein Structure Initiative (PSI), including protein family classification and target selection, generation of protein for biophysical analyses, sample preparation for structural studies, structure determination and analyses, and dissemination of results. At the end of the PSI Pilot Study Phase (PSI-1), the NYSGXRC will be capable of producing 100-200 experimentally determined protein structures annually. All Consortium activities can be scaled to increase production capacity significantly during the Production Phase of the PSI (PSI-2). The Consortium utilizes both centralized and de-centralized production teams with clearly defined deliverables and hand-off procedures that are supported by a web-based target/sample tracking system (SGX Laboratory Information Data Management System, LIMS, and NYSGXRC Internal Consortium Experimental Database, ICE-DB). Consortium management is provided by an Executive Committee, which is composed of the PI and all Co-PIs. Progress to date is tracked on a publicly available Consortium web site (http://www.nysgxrc. org) and all DNA/protein reagents and experimental protocols are distributed freely from the New York City Area institutions. In addition to meeting the requirements of the Pilot Study Phase and preparing for the Production Phase of the PSI, the NYSGXRC aims to develop modular technologies that are transferable to structural biology laboratories in both academe and industry. The NYSGXRC PI and Co-PIs intend the PSI to have a transforming effect on the disciplines of X-ray crystallography and NMR spectroscopy of biological macromolecules. Working with other PSI-funded Centers, the NYSGXRC seeks to create the structural biology laboratory of the future. Herein, we present an overview of the organization of the NYSGXRC and describe progress toward development of a high-throughput Gene→Structure platform. An analysis of current and projected consortium metrics reflects progress to date and delineates opportunities for further technology development.

Original languageEnglish (US)
Pages (from-to)225-232
Number of pages8
JournalJournal of Structural and Functional Genomics
Volume6
Issue number2-3
DOIs
StatePublished - Sep 2005

Fingerprint

Research
Proteins
Information management
National Institute of General Medical Sciences (U.S.)
Industrial research
Information Management
X ray crystallography
X Ray Crystallography
Macromolecules
Information Systems
Nuclear magnetic resonance spectroscopy
Websites
Industry
Magnetic Resonance Spectroscopy
Hand
Throughput
Organizations
Databases
Technology
Network protocols

Keywords

  • Crystallography
  • NYSGXRC
  • Protein structure initiative
  • Structural genomics

ASJC Scopus subject areas

  • Genetics
  • Structural Biology
  • Biochemistry

Cite this

New York-Structural GenomiX Research Consortium (NYSGXRC) : A large scale center for the protein structure initiative. / Bonanno, Jeffrey B.; Almo, Steven C.; Bresnick, Anne R.; Chance, Mark R.; Fiser, Andras; Swaminathan, S.; Jiang, J.; Studier, F. William; Shapiro, Lawrence; Lima, Christopher D.; Gaasterland, Theresa M.; Sali, Andrej; Bain, Kevin; Feil, Ingeborg; Gao, Xia; Lorimer, Don; Ramos, Aurora; Sauder, J. Michael; Wasserman, Steven R.; Emtage, Spencer; D'Amico, Kevin L.; Burley, Stephen K.

In: Journal of Structural and Functional Genomics, Vol. 6, No. 2-3, 09.2005, p. 225-232.

Research output: Contribution to journalArticle

Bonanno, JB, Almo, SC, Bresnick, AR, Chance, MR, Fiser, A, Swaminathan, S, Jiang, J, Studier, FW, Shapiro, L, Lima, CD, Gaasterland, TM, Sali, A, Bain, K, Feil, I, Gao, X, Lorimer, D, Ramos, A, Sauder, JM, Wasserman, SR, Emtage, S, D'Amico, KL & Burley, SK 2005, 'New York-Structural GenomiX Research Consortium (NYSGXRC): A large scale center for the protein structure initiative', Journal of Structural and Functional Genomics, vol. 6, no. 2-3, pp. 225-232. https://doi.org/10.1007/s10969-005-6827-0
Bonanno, Jeffrey B. ; Almo, Steven C. ; Bresnick, Anne R. ; Chance, Mark R. ; Fiser, Andras ; Swaminathan, S. ; Jiang, J. ; Studier, F. William ; Shapiro, Lawrence ; Lima, Christopher D. ; Gaasterland, Theresa M. ; Sali, Andrej ; Bain, Kevin ; Feil, Ingeborg ; Gao, Xia ; Lorimer, Don ; Ramos, Aurora ; Sauder, J. Michael ; Wasserman, Steven R. ; Emtage, Spencer ; D'Amico, Kevin L. ; Burley, Stephen K. / New York-Structural GenomiX Research Consortium (NYSGXRC) : A large scale center for the protein structure initiative. In: Journal of Structural and Functional Genomics. 2005 ; Vol. 6, No. 2-3. pp. 225-232.
@article{e0963f9eea9d4efd8c573651a1854f78,
title = "New York-Structural GenomiX Research Consortium (NYSGXRC): A large scale center for the protein structure initiative",
abstract = "Structural GenomiX, Inc. (SGX), four New York area institutions, and two University of California schools have formed the New York Structural GenomiX Research Consortium (NYSGXRC), an industrial/academic Research Consortium that exploits individual core competencies to support all aspects of the NIH-NIGMS funded Protein Structure Initiative (PSI), including protein family classification and target selection, generation of protein for biophysical analyses, sample preparation for structural studies, structure determination and analyses, and dissemination of results. At the end of the PSI Pilot Study Phase (PSI-1), the NYSGXRC will be capable of producing 100-200 experimentally determined protein structures annually. All Consortium activities can be scaled to increase production capacity significantly during the Production Phase of the PSI (PSI-2). The Consortium utilizes both centralized and de-centralized production teams with clearly defined deliverables and hand-off procedures that are supported by a web-based target/sample tracking system (SGX Laboratory Information Data Management System, LIMS, and NYSGXRC Internal Consortium Experimental Database, ICE-DB). Consortium management is provided by an Executive Committee, which is composed of the PI and all Co-PIs. Progress to date is tracked on a publicly available Consortium web site (http://www.nysgxrc. org) and all DNA/protein reagents and experimental protocols are distributed freely from the New York City Area institutions. In addition to meeting the requirements of the Pilot Study Phase and preparing for the Production Phase of the PSI, the NYSGXRC aims to develop modular technologies that are transferable to structural biology laboratories in both academe and industry. The NYSGXRC PI and Co-PIs intend the PSI to have a transforming effect on the disciplines of X-ray crystallography and NMR spectroscopy of biological macromolecules. Working with other PSI-funded Centers, the NYSGXRC seeks to create the structural biology laboratory of the future. Herein, we present an overview of the organization of the NYSGXRC and describe progress toward development of a high-throughput Gene→Structure platform. An analysis of current and projected consortium metrics reflects progress to date and delineates opportunities for further technology development.",
keywords = "Crystallography, NYSGXRC, Protein structure initiative, Structural genomics",
author = "Bonanno, {Jeffrey B.} and Almo, {Steven C.} and Bresnick, {Anne R.} and Chance, {Mark R.} and Andras Fiser and S. Swaminathan and J. Jiang and Studier, {F. William} and Lawrence Shapiro and Lima, {Christopher D.} and Gaasterland, {Theresa M.} and Andrej Sali and Kevin Bain and Ingeborg Feil and Xia Gao and Don Lorimer and Aurora Ramos and Sauder, {J. Michael} and Wasserman, {Steven R.} and Spencer Emtage and D'Amico, {Kevin L.} and Burley, {Stephen K.}",
year = "2005",
month = "9",
doi = "10.1007/s10969-005-6827-0",
language = "English (US)",
volume = "6",
pages = "225--232",
journal = "Journal of Structural and Functional Genomics",
issn = "1345-711X",
publisher = "Springer Netherlands",
number = "2-3",

}

TY - JOUR

T1 - New York-Structural GenomiX Research Consortium (NYSGXRC)

T2 - A large scale center for the protein structure initiative

AU - Bonanno, Jeffrey B.

AU - Almo, Steven C.

AU - Bresnick, Anne R.

AU - Chance, Mark R.

AU - Fiser, Andras

AU - Swaminathan, S.

AU - Jiang, J.

AU - Studier, F. William

AU - Shapiro, Lawrence

AU - Lima, Christopher D.

AU - Gaasterland, Theresa M.

AU - Sali, Andrej

AU - Bain, Kevin

AU - Feil, Ingeborg

AU - Gao, Xia

AU - Lorimer, Don

AU - Ramos, Aurora

AU - Sauder, J. Michael

AU - Wasserman, Steven R.

AU - Emtage, Spencer

AU - D'Amico, Kevin L.

AU - Burley, Stephen K.

PY - 2005/9

Y1 - 2005/9

N2 - Structural GenomiX, Inc. (SGX), four New York area institutions, and two University of California schools have formed the New York Structural GenomiX Research Consortium (NYSGXRC), an industrial/academic Research Consortium that exploits individual core competencies to support all aspects of the NIH-NIGMS funded Protein Structure Initiative (PSI), including protein family classification and target selection, generation of protein for biophysical analyses, sample preparation for structural studies, structure determination and analyses, and dissemination of results. At the end of the PSI Pilot Study Phase (PSI-1), the NYSGXRC will be capable of producing 100-200 experimentally determined protein structures annually. All Consortium activities can be scaled to increase production capacity significantly during the Production Phase of the PSI (PSI-2). The Consortium utilizes both centralized and de-centralized production teams with clearly defined deliverables and hand-off procedures that are supported by a web-based target/sample tracking system (SGX Laboratory Information Data Management System, LIMS, and NYSGXRC Internal Consortium Experimental Database, ICE-DB). Consortium management is provided by an Executive Committee, which is composed of the PI and all Co-PIs. Progress to date is tracked on a publicly available Consortium web site (http://www.nysgxrc. org) and all DNA/protein reagents and experimental protocols are distributed freely from the New York City Area institutions. In addition to meeting the requirements of the Pilot Study Phase and preparing for the Production Phase of the PSI, the NYSGXRC aims to develop modular technologies that are transferable to structural biology laboratories in both academe and industry. The NYSGXRC PI and Co-PIs intend the PSI to have a transforming effect on the disciplines of X-ray crystallography and NMR spectroscopy of biological macromolecules. Working with other PSI-funded Centers, the NYSGXRC seeks to create the structural biology laboratory of the future. Herein, we present an overview of the organization of the NYSGXRC and describe progress toward development of a high-throughput Gene→Structure platform. An analysis of current and projected consortium metrics reflects progress to date and delineates opportunities for further technology development.

AB - Structural GenomiX, Inc. (SGX), four New York area institutions, and two University of California schools have formed the New York Structural GenomiX Research Consortium (NYSGXRC), an industrial/academic Research Consortium that exploits individual core competencies to support all aspects of the NIH-NIGMS funded Protein Structure Initiative (PSI), including protein family classification and target selection, generation of protein for biophysical analyses, sample preparation for structural studies, structure determination and analyses, and dissemination of results. At the end of the PSI Pilot Study Phase (PSI-1), the NYSGXRC will be capable of producing 100-200 experimentally determined protein structures annually. All Consortium activities can be scaled to increase production capacity significantly during the Production Phase of the PSI (PSI-2). The Consortium utilizes both centralized and de-centralized production teams with clearly defined deliverables and hand-off procedures that are supported by a web-based target/sample tracking system (SGX Laboratory Information Data Management System, LIMS, and NYSGXRC Internal Consortium Experimental Database, ICE-DB). Consortium management is provided by an Executive Committee, which is composed of the PI and all Co-PIs. Progress to date is tracked on a publicly available Consortium web site (http://www.nysgxrc. org) and all DNA/protein reagents and experimental protocols are distributed freely from the New York City Area institutions. In addition to meeting the requirements of the Pilot Study Phase and preparing for the Production Phase of the PSI, the NYSGXRC aims to develop modular technologies that are transferable to structural biology laboratories in both academe and industry. The NYSGXRC PI and Co-PIs intend the PSI to have a transforming effect on the disciplines of X-ray crystallography and NMR spectroscopy of biological macromolecules. Working with other PSI-funded Centers, the NYSGXRC seeks to create the structural biology laboratory of the future. Herein, we present an overview of the organization of the NYSGXRC and describe progress toward development of a high-throughput Gene→Structure platform. An analysis of current and projected consortium metrics reflects progress to date and delineates opportunities for further technology development.

KW - Crystallography

KW - NYSGXRC

KW - Protein structure initiative

KW - Structural genomics

UR - http://www.scopus.com/inward/record.url?scp=26444608688&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=26444608688&partnerID=8YFLogxK

U2 - 10.1007/s10969-005-6827-0

DO - 10.1007/s10969-005-6827-0

M3 - Article

C2 - 16211523

AN - SCOPUS:26444608688

VL - 6

SP - 225

EP - 232

JO - Journal of Structural and Functional Genomics

JF - Journal of Structural and Functional Genomics

SN - 1345-711X

IS - 2-3

ER -